-
Founded in:
1992-08-21 -
Country:
China -
Address:
No. 317, Xinluo Street, High-tech Zone, Jinan City, Shandong Province -
Tax NO.:
91370000614073351Q -
Registered Funds:
600 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Tropisetron hydrochloride |
Extract from the above information
More
Extract from the above information |
105826-92-4 | 16 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Amikacin sulfate salt |
Aminoglycoside antibiotics have antibacterial effects on most Enterobacteriaceae, Pseudomonas aeruginosa, some other Pseudomonas, Acinetobacter, Alcaligenes, meningococci, gonococci, influenza bacilli, Yersinia, Campylobacter fetus, Mycobacterium tuberculosis and some Mycobacterium. The mechanism of action is to act on the 30S subunit of bacterial ribosomes and inhibit bacterial protein synthesis. Combination with semi-synthetic penicillins or cephalosporins often produces synergistic antibacterial effects.
More
Aminoglycoside antibiotics have antibacterial effects on most Enterobacteriaceae, Pseudomonas aeruginosa, some other Pseudomonas, Acinetobacter, Alcaligenes, meningococci, gonococci, influenza bacilli, Yersinia, Campylobacter fetus, Mycobacterium tuberculosis and some Mycobacterium. The mechanism of action is to act on the 30S subunit of bacterial ribosomes and inhibit bacterial protein synthesis. Combination with semi-synthetic penicillins or cephalosporins often produces synergistic antibacterial effects. |
149022-22-0 | 9 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Hydroxyurea |
It is a nucleoside diphosphate reductase inhibitor that can prevent nucleotides from being reduced to deoxynucleotides, interfere with the biosynthesis of purine and pyrimidine bases, selectively inhibit DNA synthesis, and have no blocking effect on RNA and protein synthesis. It is a cycle-specific drug, and is sensitive to S-phase cells.
More
It is a nucleoside diphosphate reductase inhibitor that can prevent nucleotides from being reduced to deoxynucleotides, interfere with the biosynthesis of purine and pyrimidine bases, selectively inhibit DNA synthesis, and have no blocking effect on RNA and protein synthesis. It is a cycle-specific drug, and is sensitive to S-phase cells. |
127-07-1 | 14 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Granisetron Hydrochloride |
Extract from the above information
More
Extract from the above information |
107007-99-8 | 35 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| PEGylated recombinant human granulocyte-stimulating factor (PEG-rhG-CSF) |
Granulocyte stimulating factor binds to the surface receptors of hematopoietic cells and acts on hematopoietic cells, thereby stimulating proliferation, differentiation, typing and activation of mature cell functions. Compared with rhG-CSF, PEG-rhG-CSF can reduce plasma clearance rate and prolong half-life.
More
Granulocyte stimulating factor binds to the surface receptors of hematopoietic cells and acts on hematopoietic cells, thereby stimulating proliferation, differentiation, typing and activation of mature cell functions. Compared with rhG-CSF, PEG-rhG-CSF can reduce plasma clearance rate and prolong half-life. |
0 |